M
Mehmet Toner
Researcher at Harvard University
Publications - 572
Citations - 60830
Mehmet Toner is an academic researcher from Harvard University. The author has contributed to research in topics: Circulating tumor cell & Cancer. The author has an hindex of 113, co-authored 550 publications receiving 54827 citations. Previous affiliations of Mehmet Toner include University of New Mexico & University of Notre Dame.
Papers
More filters
Journal ArticleDOI
Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor
TL;DR: Investigation of the viability and synthetic function of rat hepatocytes cocultured with 3T3-J2 fibroblasts in a small-scale microchannel flat-plate bioreactor with and without an internal membrane oxygenator under flow showed that theBioreactor without the oxygenator resulted in significantly decreased viability and function of hepatocytes, whereas hepatocytes in the bioreactors with internal membranes oxygenator were able to maintain their viability andfunction.
Journal ArticleDOI
The promise of organ and tissue preservation to transform medicine
Sebastian Giwa,Jedediah K. Lewis,Luis M. Alvarez,Luis M. Alvarez,Luis M. Alvarez,Robert Langer,Alvin E. Roth,George M. Church,James F. Markmann,David H. Sachs,Anil Chandraker,Anil Chandraker,Jason A. Wertheim,Martine Rothblatt,Edward S. Boyden,Elling Eidbo,W. P. Andrew Lee,Bohdan Pomahac,Gerald Brandacher,David M. Weinstock,Gloria D. Elliott,David R. Nelson,Jason P. Acker,Korkut Uygun,Boris Schmalz,Boris Schmalz,Brad P Weegman,Alessandro Tocchio,Greg M Fahy,Kenneth B. Storey,Boris Rubinsky,John C. Bischof,Janet A.W. Elliott,Teresa K. Woodruff,G. John Morris,Utkan Demirci,Kelvin G. M. Brockbank,Erik J. Woods,Robert N. Ben,John G. Baust,Dayong Gao,Barry Fuller,Yoed Rabin,David C. Kravitz,Michael J. Taylor,Michael J. Taylor,Mehmet Toner +46 more
TL;DR: Developments indicate that a new paradigm, integrating multiple existing preservation approaches and new technologies that have flourished in the past 10 years, could transform preservation research.
Journal ArticleDOI
Advancing the speed, sensitivity and accuracy of biomolecular detection using multi-length-scale engineering
Shana O. Kelley,Chad A. Mirkin,David R. Walt,Rustem F. Ismagilov,Mehmet Toner,Edward H. Sargent +5 more
TL;DR: Recent strategies that combine nano- and microscale materials and devices to produce large improvements in detection sensitivity, speed and accuracy, allowing previously undetectable biomarkers to be identified in clinical samples are reviewed.
Journal ArticleDOI
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses
Tilak K. Sundaresan,Lecia V. Sequist,John V. Heymach,Gregory J. Riely,Pasi A. Jänne,Walter H. Koch,James P. Sullivan,Douglas B. Fox,Robert C. Maher,Alona Muzikansky,Andrew Webb,Hai T. Tran,Uma Giri,Martin Fleisher,Helena A. Yu,Wen Wei,Bruce E. Johnson,Tom Barber,John R. Walsh,Jeffrey A. Engelman,Shannon L. Stott,Ravi Kapur,Shyamala Maheswaran,Mehmet Toner,Daniel A. Haber,Daniel A. Haber +25 more
TL;DR: In this paper, the T790M gatekeeper mutation in the EGFR is acquired by some NSCLC patients as they become resistant to selective tyrosine kinase inhibitors (TKI).
Journal ArticleDOI
HER2 expression identifies dynamic functional states within circulating breast cancer cells
Nicole Vincent Jordan,Aditya Bardia,Ben S. Wittner,Cyril H. Benes,Matteo Ligorio,Yu Zheng,Min Yu,Tilak K. Sundaresan,Joseph A. LiCausi,Rushil Desai,Ryan M. O'Keefe,Richard Y. Ebright,Myriam Boukhali,Srinjoy Sil,Maristela L. Onozato,Anthony J. Iafrate,Ravi Kapur,Dennis C. Sgroi,David T. Ting,Mehmet Toner,Sridhar Ramaswamy,Wilhelm Haas,Shyamala Maheswaran,Daniel A. Haber,Daniel A. Haber +24 more
TL;DR: Combined treatment with paclitaxel and Notch inhibitors achieves sustained suppression of tumorigenesis in orthotopic circulating tumour cell-derived tumour models and points to distinct yet interconverting phenotypes within patient-derived circulating tumours, contributing to progression of breast cancer and acquisition of drug resistance.